Shows
GN in TenEpisode 5: Industry Perspective with Jula Inrig: Endothelin Antagonism, IgAN, FSGS, Clinical Trial Career Paths, and the New Era of Nephrology TrialsIn this episode, Kenar and Koyal talk with Dr. Jula Inrig about endothelin physiology and different approaches to endothelin antagonism, trials of sparsentan in IgAN and FSGS, the art and science of clinical trial design, career paths in clinical research outside academia, and how we got to our current era of plentiful nephrology clinical trials.Disclosure: Jula Inrig is the Chief Medical Officer of Travere Therapeutics, which is one of multiple corporate partners that provide financial support to ISGD. Dr. Inrig also serves independently on the ISGD Steering Committee as a representative of industry...2024-04-2624 min
ASN PodcastASN Kidney Week 2015 Day 3 PodcastASN President Jonathan Himmelfarb, MD, FASN, discusses Day 3 of Kidney Week with Dr. Neil Powe, Dr. Jula Inrig, and Dr. Wolfgang Winkelmayer. ASN Kidney Week Podcasts are supported by OPKO Renal.2015-11-0720 min